Stay updated on TRx0237 in Mild Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the TRx0237 in Mild Alzheimer's Disease Clinical Trial page.

Latest updates to the TRx0237 in Mild Alzheimer's Disease Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page has undergone significant content removal regarding a clinical study for TRx0237 in treating mild Alzheimer's Disease, including detailed inclusion and exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference20%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check57 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check93 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to TRx0237 in Mild Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRx0237 in Mild Alzheimer's Disease Clinical Trial page.